首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >An amplified comparative fluorescence resonance energy transfer immunosensing of CA125 tumor marker and ovarian cancer cells using green and economic carbon dots for bio-applications in labeling, imaging and sensing
【24h】

An amplified comparative fluorescence resonance energy transfer immunosensing of CA125 tumor marker and ovarian cancer cells using green and economic carbon dots for bio-applications in labeling, imaging and sensing

机译:使用绿色和经济碳点对标签,成像和传感的生物应用的CA125肿瘤标志物和卵巢癌细胞的扩增的比较荧光共振能量转移免疫抑制

获取原文
获取原文并翻译 | 示例
           

摘要

CA125, is a marker in the clinical diagnosis of several cancers and currently is the best serum-based tumor marker for ovarian cancer. Here, we developed an ultrasensitive antibody-ssDNA aptamer sandwich-type fluorescence immunosensor for CA125 detection. Based on a novel signal amplification strategy the carbon dots (CDs) functionalized with aptamer (CD-aptamer) used as detection probe and PAMAM-Dendrimers/AuNPs was used for covalent attachment of CA125-antibody and completing the sandwich assay method. By measuring of fluorescence resonance energy transfer (FRET) signals between CDs and AuNPs as nanoquenchers, the fluorescence signal quenched during sandwich complex formed between anti-CA125, CA125 and CDs-Aptamer and decreasing of fluorescence response signal is related to CA125 concentrations. Under optimal conditions, the immunosensor exhibited an extremely low calculated detection limit of 0.5 f g/mL with wide linear range 1.0 fg/mL to 1.0 ng/mL of CA 125. The application of the immunosensor for CA125 detection in serum samples and measuring of ovarian-cancer cells was also investigated. The immunosensor revealed good sensitivity and specificity with ovarian cell concentrations from 2.5x10(3) to 2x10(4) cells/mL with correlation coefficient of 0.9937 and detection limit of 400 cells/mL (4 cell in 10 mu L), indicating potential application of immunosensor in clinical monitoring of tumor biomarkers. Furthermore, the cell viability was not changed upon treatment with CDs probe during 24 h, showing the low cytotoxicity of the probe. More importantly, CDs-antibody hybrid was achieved in selective imaging of the cancer cells over the OVCAR-3 line cells, implying its potential applications in biosensing, as well as in cancer diagnosis.
机译:CA125是一种标记在几种癌症的临床诊断中,目前是卵巢癌的最佳血清肿瘤标志物。在这里,我们开发了一种用于CA125检测的超敏感抗体-SSDNA适体夹层夹层型荧光免疫传感器。基于新颖的信号放大策略,使用用作检测探针和PAMAM-树枝状大分子/ AUNP的适体(CD-Aptamer)官能化的碳点(CDS)用于Ca125-抗体的共价附着,并完成夹心测定法。通过测量CDS和AUNPS之间的荧光共振能量转移(FRET)信号作为纳米闭塞器,在抗CA125,CA125和CDS-适体之间形成的夹层复合物期间猝灭的荧光信号和荧光响应信号的降低与CA125浓度有关。在最佳条件下,免疫传感器具有宽线性范围1.0fg / ml至1.0ng / ml Ca 12 5的0.5fg / ml的极低计算的检测限。免疫传感器在血清样品中的血清样本中的检测和卵巢测量的应用还研究了癌细胞。免疫传感器揭示了从2.5×10(3)至2×10(4)个细胞/ mL的卵巢细胞浓度良好的敏感性和特异性,其相关系数为0.9937,检测极限为400个细胞/ ml(4个细胞10μl),表明潜在应用肿瘤生物标志物临床监测中的免疫传感器。此外,在24小时内用CDS探针治疗时,细胞活力不会改变,显示探针的低细胞毒性。更重要的是,CdS-抗体杂交液在癌细胞对癌细胞的选择性成像中实现,暗示其在生物传感和癌症诊断中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号